FDA Panel to Mull Diabetic Eye Disease Drug

(MedPage Today) -- Ranibizumab (Lucentis) helped improve vision for diabetic patients with macular edema, according to FDA reviewers, but the drug's higher of two doses comes with more adverse events.

Full Story →